IL106725A - Pharmaceutical composition for treating inflammatory bowel disease comprising IL-10 - Google Patents

Pharmaceutical composition for treating inflammatory bowel disease comprising IL-10

Info

Publication number
IL106725A
IL106725A IL10672593A IL10672593A IL106725A IL 106725 A IL106725 A IL 106725A IL 10672593 A IL10672593 A IL 10672593A IL 10672593 A IL10672593 A IL 10672593A IL 106725 A IL106725 A IL 106725A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
inflammatory bowel
bowel disease
treating inflammatory
treating
Prior art date
Application number
IL10672593A
Other languages
English (en)
Other versions
IL106725A0 (en
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/932,900 external-priority patent/US5368854A/en
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of IL106725A0 publication Critical patent/IL106725A0/xx
Publication of IL106725A publication Critical patent/IL106725A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
IL10672593A 1992-08-20 1993-08-18 Pharmaceutical composition for treating inflammatory bowel disease comprising IL-10 IL106725A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/932,900 US5368854A (en) 1992-08-20 1992-08-20 Use of IL-10 to treat inflammatory bowel disease
US93341992A 1992-08-21 1992-08-21
US93346292A 1992-08-21 1992-08-21
US93395092A 1992-08-21 1992-08-21

Publications (2)

Publication Number Publication Date
IL106725A0 IL106725A0 (en) 1993-12-08
IL106725A true IL106725A (en) 2000-12-06

Family

ID=27506019

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10672593A IL106725A (en) 1992-08-20 1993-08-18 Pharmaceutical composition for treating inflammatory bowel disease comprising IL-10

Country Status (22)

Country Link
EP (2) EP0801951A3 (fr)
JP (1) JP3494647B2 (fr)
KR (1) KR0170037B1 (fr)
CN (1) CN1090204A (fr)
AT (1) ATE162947T1 (fr)
AU (1) AU680628B2 (fr)
CA (1) CA2142861C (fr)
CZ (1) CZ283488B6 (fr)
DE (1) DE69316921T2 (fr)
DK (1) DK0671933T3 (fr)
ES (1) ES2111769T3 (fr)
FI (1) FI950697L (fr)
GR (1) GR3026635T3 (fr)
HU (1) HU220103B (fr)
IL (1) IL106725A (fr)
MX (1) MX9305054A (fr)
MY (1) MY111402A (fr)
PL (1) PL307566A1 (fr)
RU (1) RU2120802C1 (fr)
SK (1) SK21195A3 (fr)
TW (1) TW243415B (fr)
WO (1) WO1994004180A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2155109A1 (fr) * 1993-02-01 1994-08-18 Daniel Abramowicz Utilisation d'une composition pharmaceutique renfermant une quantite efficace d'interleukine-10, un analogue et (ou) un agoniste d'interleukine-10
MX9606537A (es) * 1994-07-05 1997-12-31 Steeno Res Group As Inmunomoduladores.
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
CA2205572A1 (fr) * 1994-12-12 1996-06-20 Beth Israel Hospital Association Cytokines chimeres et emplois de celles-ci
US5770190A (en) * 1995-07-14 1998-06-23 Schering Corporation Method of treatment of acute leukemia with inteleukin-10
EP0756871A1 (fr) * 1995-08-01 1997-02-05 Institut Pasteur Utilisation d'une composition pharmaceutique comprenant une dose efficace d'interleukine-10, d'un analogue et/ou d'un agoniste d'interleukine-10
WO1997038695A1 (fr) * 1996-04-17 1997-10-23 Prendergast Patrick T Therapie associee reposant sur l'utilisation de la dehydroepiandrosterone (dhea)
AU5532098A (en) * 1996-12-20 1998-07-17 Magainin Pharmaceuticals, Inc. A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis
AU5221998A (en) * 1997-04-17 1998-11-13 Patrick T. Prendergast Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6001651A (en) * 1998-03-20 1999-12-14 Isis Pharmaceuticals Inc. Antisense modulation of LFA-3
EP1123314B1 (fr) * 1998-10-20 2004-02-18 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Utilisation d'une souche de lactococcus produisant des cytokines pour traiter la colite
RU2140283C1 (ru) * 1998-12-15 1999-10-27 Товарищество с ограниченной ответственностью "Биотех" Фармацевтический препарат на основе интерлейкина-2 (варианты)
DE60017115T2 (de) 1999-02-10 2005-12-08 Mitsubishi Pharma Corp. Amid-derivate und deren medizinische verwendung
EP1234181A4 (fr) * 1999-12-03 2005-01-26 Baxter Int Essai de pyrogenicite a utiliser avec des systemes de dosage immunologique automatises
EP1283722A1 (fr) * 2000-03-31 2003-02-19 Idec Pharmaceuticals Corporation Utilisation combinee d'anticorps ou d'antagonistes anti-cytokine et d'anti-cd20 pour le traitement du lymphome b
EP1284747A2 (fr) 2000-05-12 2003-02-26 Beth Israel Deaconess Medical Center, Inc. Compositions et procedes pour obtenir une suppression immune
RU2196605C2 (ru) * 2000-12-07 2003-01-20 Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Способ получения растворимых конъюгатов биологически активных веществ
RU2202363C2 (ru) * 2001-04-09 2003-04-20 Ершов Феликс Иванович Способ определения чувствительности живого организма и/или его клеток к воздействию вещества, поля или комбинации веществ и/или полей
US20040197304A1 (en) 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
US7261882B2 (en) * 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
PE20090047A1 (es) 2003-11-10 2009-01-26 Schering Corp Anticuerpo recombinante humanizado anti-interleuquina 10
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
EP2261323A1 (fr) 2005-05-31 2010-12-15 The Iams Company Lactobacilles probiotiques félins
US20080254014A1 (en) * 2005-10-03 2008-10-16 Actogenix N V Use of Recombinant Yeast Strain Producing an Anti-Inflammatory Compound to Treat Colitis
NZ597098A (en) * 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
WO2008093303A2 (fr) 2007-02-01 2008-08-07 The Iams Company Procédé de réduction de l'inflammation et du stress chez un mammifère
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2986306A4 (fr) * 2013-04-18 2016-12-07 Armo Biosciences Inc Méthodes d'utilisation de l'interleukine-10 pour le traitement de maladies et de troubles
CA2914837A1 (fr) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Methode d'evaluation de l'identite et de la stabilite d'une proteine
SI3021873T1 (sl) 2013-07-18 2018-12-31 Xalud Therapeutics, Inc. Sestavek za zdravljenje vnetne sklepne bolezni
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
CA2995120A1 (fr) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Procedes d'utilisation de l'interleukine-10 pour le traitement de maladies et de troubles
CN114349858B (zh) * 2022-01-26 2022-07-01 优睿赛思(武汉)生物科技有限公司 抗人白介素-10高亲和力兔单克隆抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
DE69201128T2 (de) * 1991-01-16 1995-05-24 Schering Corp Behandlung von neoplastischen krankenheiten mit interleukin-10.
GB9207732D0 (en) * 1992-04-06 1992-05-27 Isis Innovation Wound repair

Also Published As

Publication number Publication date
WO1994004180A3 (fr) 1994-06-09
ES2111769T3 (es) 1998-03-16
JPH08500362A (ja) 1996-01-16
EP0671933B1 (fr) 1998-02-04
HK1004326A1 (en) 1998-11-20
HU9500467D0 (en) 1995-04-28
AU680628B2 (en) 1997-08-07
WO1994004180A2 (fr) 1994-03-03
KR950702841A (ko) 1995-08-23
MY111402A (en) 2000-04-29
EP0801951A2 (fr) 1997-10-22
HUT70976A (en) 1995-11-28
HU220103B (hu) 2001-10-28
DE69316921T2 (de) 1998-06-04
JP3494647B2 (ja) 2004-02-09
PL307566A1 (en) 1995-05-29
FI950697A0 (fi) 1995-02-16
CZ283488B6 (cs) 1998-04-15
ATE162947T1 (de) 1998-02-15
SK21195A3 (en) 1996-10-02
CN1090204A (zh) 1994-08-03
EP0671933A1 (fr) 1995-09-20
RU2120802C1 (ru) 1998-10-27
IL106725A0 (en) 1993-12-08
CZ44195A3 (en) 1995-10-18
TW243415B (fr) 1995-03-21
FI950697A7 (fi) 1995-04-07
AU5010893A (en) 1994-03-15
FI950697L (fi) 1995-04-07
DK0671933T3 (da) 1998-09-23
CA2142861A1 (fr) 1994-03-03
GR3026635T3 (en) 1998-07-31
CA2142861C (fr) 2000-08-15
DE69316921D1 (de) 1998-03-12
EP0801951A3 (fr) 1998-05-20
RU95108330A (ru) 1996-11-27
MX9305054A (es) 1994-02-28
KR0170037B1 (ko) 1999-02-01

Similar Documents

Publication Publication Date Title
TW243415B (fr)
PH19733A (en) Aromatic heterocyclic esters of steroids,pharmaceutical compositions containing them and their use
GB9208339D0 (en) Treatment composition
LV12284A (lv) No kudras izdaliti bioaktivi produkti un tos saturosas farmaceitiskas un kosmetiskas kompozicijas
EP0584877A3 (en) Viscoelastic personal care composition
BR9106864A (pt) Composicoes de liberacao prolongada para o tratamento de doencas periodontais
EP0357675A4 (en) Pyridooxazinone-pyridone compounds, cardiotonic compositions including the same, and their uses
ZA944923B (en) Iodinated oligomeric compounds and diagnostic compositions containing the same
IL87421A (en) Pharmaceutical compositions containing 5-amino (or substituted amino) - 1,2,3-triazoles
GB9102816D0 (en) Quenching and deodorizing compositions
IL89392A (en) Compositions for the treatment of osteoporosis in humans comprising 24, 25-dihydroxy-vitamin d3
DE69327693D1 (de) Interferon-Alpha/Beta bindendes Protein, seine Herstellung und seine enthaltende pharmazeutische Zusammensetzungen
IL104132A0 (en) Compositions for the treatment of mammalian diseases
IL105285A0 (en) Compositions for the treatment of diabetes
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
GB9217547D0 (en) Leather treatment compositions
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
EP0556546A3 (en) Viricidal disinfecting composition
IL105229A0 (en) The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters as medicaments
GB2279567B (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
ZA931062B (en) Compositions for the treatment of glaucoma.
IL119421A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
MY116727A (en) Tetrahydropyrido compounds
GB9022298D0 (en) Treatment composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force